Mrs Tarnisha Fitzgerald, CRNP, FNP-BC in Lutherville, MD - Medicare Nurse Practitioner

Mrs Tarnisha Fitzgerald, CRNP, FNP-BC is a medicare enrolled "Nurse Practitioner - Family" in Lutherville, Maryland. Her current practice location is 1301 York Rd Ste 800, Lutherville, Maryland. You can reach out to her office (for appointments etc.) via phone at (844) 481-0217.

Mrs Tarnisha Fitzgerald is licensed to practice in Maryland (license number R188175) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1164940656.

Contact Information

	Mrs Tarnisha Fitzgerald, CRNP, FNP-BC
	1301 York Rd Ste 800, Lutherville, MD 21093-6011
	(844) 481-0217
	Not Available

Provider's Profile

Full Name	Mrs Tarnisha Fitzgerald
Gender	Female
Speciality	Nurse Practitioner - Family
Location	1301 York Rd Ste 800, Lutherville, Maryland
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1164940656
Provider Enumeration Date: 09/05/2017
Last Update Date: 03/29/2024

Medicare PECOS Information:

PECOS PAC ID: 7214284645
Enrollment ID: I20180717001722

Medical Identifiers

Medical identifiers for Mrs Tarnisha Fitzgerald such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1164940656	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
363LF0000X	Nurse Practitioner - Family	R188175 (Maryland)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mrs Tarnisha Fitzgerald allows following entities to bill medicare on her behalf.

Entity Name	Maryland Medical First Pa
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1013005016 PECOS PAC ID: 1850329715 Enrollment ID: O20050801001187

News Archive

Study: 90% of patients have detectable antibodies up to 7 months post contracting COVID-19

A new study led by Marc Veldhoen, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) with an interdisciplinary team of clinicians and researchers from Faculdade de Medicina da Universidade de Lisboa (FMUL) and Centro Hospitalar Lisboa Norte (CHLN) and collaborators at Instituto Português do Sangue e Transplantação (IPST), shows that 90% of subjects have detectable antibodies 40 days up to 7 months post contracting COVID-19.

FDA grants orphan-drug designation for Ligand's Captisol-enabled Topiramate Injection

Ligand Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation for its proprietary Captisol-enabled Topiramate Injection for the treatment of partial onset or primary generalized tonic-clonic seizures in hospitalized epilepsy patients who are unable to take oral topiramate.

Study highlights advantages and challenges of integrating GP service in hospital ED

A new study from the University of Liverpool provides evidence that locating a General Practitioner in a hospital emergency department can reduce waiting times and admissions, but may increases antibiotic prescribing.

UK's leading sight loss charity invites applications from brightest minds in ophthalmic research

Fight for Sight, the UK's leading sight loss charity, has announced that the Project Grants Awards and the recently established Primer Fellowship call is now open for applications.

Retina-on-a-chip may provide useful alternative to existing models for studying eye disease

The development of a retina-on-a-chip, which combines living human cells with an artificial tissue-like system, has been described today in the open-access journal eLife.

Entity Name	Fitzgerald Primary Care Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1902382252 PECOS PAC ID: 7214285592 Enrollment ID: O20180802001242

Study: 90% of patients have detectable antibodies up to 7 months post contracting COVID-19

FDA grants orphan-drug designation for Ligand's Captisol-enabled Topiramate Injection

Study highlights advantages and challenges of integrating GP service in hospital ED

UK's leading sight loss charity invites applications from brightest minds in ophthalmic research

Fight for Sight, the UK's leading sight loss charity, has announced that the Project Grants Awards and the recently established Primer Fellowship call is now open for applications.

Retina-on-a-chip may provide useful alternative to existing models for studying eye disease

The development of a retina-on-a-chip, which combines living human cells with an artificial tissue-like system, has been described today in the open-access journal eLife.

Entity Name	Toller Enterprises, Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1821697533 PECOS PAC ID: 8628481926 Enrollment ID: O20210105002952

Study: 90% of patients have detectable antibodies up to 7 months post contracting COVID-19

FDA grants orphan-drug designation for Ligand's Captisol-enabled Topiramate Injection

Study highlights advantages and challenges of integrating GP service in hospital ED

UK's leading sight loss charity invites applications from brightest minds in ophthalmic research

Fight for Sight, the UK's leading sight loss charity, has announced that the Project Grants Awards and the recently established Primer Fellowship call is now open for applications.

Retina-on-a-chip may provide useful alternative to existing models for studying eye disease

The development of a retina-on-a-chip, which combines living human cells with an artificial tissue-like system, has been described today in the open-access journal eLife.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Tarnisha Fitzgerald is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Tarnisha Fitzgerald, CRNP, FNP-BC 1301 York Rd Ste 800, Lutherville, MD 21093-6011 Ph: (844) 481-0217	Mrs Tarnisha Fitzgerald, CRNP, FNP-BC 1301 York Rd Ste 800, Lutherville, MD 21093-6011 Ph: (844) 481-0217

News Archive

Study: 90% of patients have detectable antibodies up to 7 months post contracting COVID-19

FDA grants orphan-drug designation for Ligand's Captisol-enabled Topiramate Injection

Study highlights advantages and challenges of integrating GP service in hospital ED

UK's leading sight loss charity invites applications from brightest minds in ophthalmic research

Fight for Sight, the UK's leading sight loss charity, has announced that the Project Grants Awards and the recently established Primer Fellowship call is now open for applications.

Retina-on-a-chip may provide useful alternative to existing models for studying eye disease

The development of a retina-on-a-chip, which combines living human cells with an artificial tissue-like system, has been described today in the open-access journal eLife.

Nurse Practitioner Nurses in Lutherville, MD

Mrs. Joanne Elizabeth Desmond, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10755 Falls Rd, Suite 260, Lutherville, MD 21093 Phone: 410-583-2955
Ms. Nelli Zafman, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10753 Falls Rd, Suite 145, Lutherville, MD 21093 Phone: 410-583-2970
Mrs. Marye Kellermann, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 31 Blondell Ct, Lutherville, MD 21093 Phone: 410-494-0398 Fax: 410-494-1445
Rebecca Millison, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 16 Westspring Way, Lutherville, MD 21093 Phone: 443-465-6937
Kayla Mardaga, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1300 York Rd Ste 30d, Lutherville, MD 21093 Phone: 443-519-2128
Erica P. Cerquetti, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2525 Pot Spring Road, Mercy Ridge Inc., Lutherville, MD 21093 Phone: 410-561-0200
Michele Andrea Donehower, C.R.N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10755 Falls Rd, Lutherville, MD 21093 Phone: 410-955-8964

Mrs Tarnisha Fitzgerald, CRNP, FNP-BC - Medicare Nurse Practitioner in Lutherville, MD

Contact Information

Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Study: 90% of patients have detectable antibodies up to 7 months post contracting COVID-19

FDA grants orphan-drug designation for Ligand's Captisol-enabled Topiramate Injection

Study highlights advantages and challenges of integrating GP service in hospital ED

UK's leading sight loss charity invites applications from brightest minds in ophthalmic research

Retina-on-a-chip may provide useful alternative to existing models for studying eye disease

Study: 90% of patients have detectable antibodies up to 7 months post contracting COVID-19

FDA grants orphan-drug designation for Ligand's Captisol-enabled Topiramate Injection

Study highlights advantages and challenges of integrating GP service in hospital ED

UK's leading sight loss charity invites applications from brightest minds in ophthalmic research

Retina-on-a-chip may provide useful alternative to existing models for studying eye disease

Study: 90% of patients have detectable antibodies up to 7 months post contracting COVID-19

FDA grants orphan-drug designation for Ligand's Captisol-enabled Topiramate Injection

Study highlights advantages and challenges of integrating GP service in hospital ED

UK's leading sight loss charity invites applications from brightest minds in ophthalmic research

Retina-on-a-chip may provide useful alternative to existing models for studying eye disease

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Study: 90% of patients have detectable antibodies up to 7 months post contracting COVID-19

FDA grants orphan-drug designation for Ligand's Captisol-enabled Topiramate Injection

Study highlights advantages and challenges of integrating GP service in hospital ED

UK's leading sight loss charity invites applications from brightest minds in ophthalmic research

Retina-on-a-chip may provide useful alternative to existing models for studying eye disease

Nurse Practitioner Nurses in Lutherville, MD